|
Is the primary tumor location (PTL) associated with differential gene expression profiles in patients with metastatic colorectal cancer (mCRC)? Analysis of the FIRE1-trial. |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Boehringer Ingelheim (Inst) |
|
|
Honoraria - Amgen; AstraZeneca; Merck KGaA; Novartis; Qiagen; Roche Pharma AG |
Consulting or Advisory Role - Amgen; AstraZeneca; Merck KGaA; Novartis; Roche Pharma AG |
Speakers' Bureau - Amgen; AstraZeneca; Merck KGaA; Qiagen; Roche Pharma AG |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Novartis; Qiagen; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Alacris Theranostics; Cellular Phenomics and Oncology |
Research Funding - Bayer; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Baxalta; Celgene; Merck; Roche; Sanofi; Sirtex Medical |
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Merck; Roche; Sanofi; Sirtex Medical |
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); IntegraGen (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sirtex Medical (Inst); Taiho Pharmaceutical (Inst) |
Travel, Accommodations, Expenses - Amgen; Baxalta; Merck; Roche; Sirtex Medical |
|
|
Honoraria - Amgen; Bayer; Merck KGaA; Roche; Sanofi; Sirtex Medical |
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Merck KGaA; Roche; Sanofi |
Travel, Accommodations, Expenses - Amgen; Bayer; Merck KGaA; Roche; Sanofi; Sirtex Medical |